世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

パルスフィールドアブレーション市場：治療領域別（心血管疾患、腫瘍性疾患、呼吸器疾患、皮膚疾患）、製品コンポーネント別（カテーテル、ジェネレーター）、応用領域別（アブレーション、アブレーションとマッピング）、アブレーションのソース別（パルスフィールドエネルギー、パルスフィールドと高周波エネルギー、パルスフィールドとクライオアブレーションエネルギー）、主要地域別（北米、欧州、アジア太平洋地域）の分布：主要企業の市場シェア、産業動向、世界予測、2023-2035年


Pulsed Field Ablation Market: Distribution by Therapeutic Area (Cardiovascular Disorders, Oncological Disorders, Respiratory Disorders and Dermatological Disorders), Product Components (Catheters and Generators), Application Areas (Ablation, and Ablation and Mapping), Source of Ablation (Pulsed Field Energy, Pulsed Field and Radiofrequency Energy, and Pulsed Field and Cryoablation Energy), Key Geographical Regions (North America, Europe and Asia-Pacific): Market Share of Key Companies, Industry Trends and Global Forecasts, 2023-2035

パルスフィールドアブレーション市場は、2023年から2035年の予測期間中に年平均成長率40％で成長し、2035年までに55億米ドルに達すると予測されている。 近年、医療従事者の間では、特に心房細動のような状態... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
Roots Analysis
ルーツアナリシス 		2023年9月27日 US$4,799
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		325 英語

　

サマリー

パルスフィールドアブレーション市場は、2023年から2035年の予測期間中に年平均成長率40％で成長し、2035年までに55億米ドルに達すると予測されている。

近年、医療従事者の間では、特に心房細動のような状態において、患者の予後をより良くするために侵襲性の低い手技を探求することに重点が置かれている。従来の手術は有効ではあるが、傷跡が残る、回復に時間がかかる、リスクが高いなどの問題がある。アブレーション療法は、手術をせずにエネルギー源を用いて異常組織を除去するもので、人気がある。しかし、熱エネルギーを使用する通常の方法は、健康な組織を傷つけ、処置後に不快感を引き起こす可能性がある。パルスフィールドアブレーション（PFA）は、より安全な選択肢として登場した。PFAは高電圧の電気パルスを短時間で使用し、健康な細胞を傷つけることなく異常組織を正確に狙い撃ちする。熱アブレーションとは異なり、PFAは組織の過熱を避けることで、リスクと回復時の不快感を軽減する。さまざまな医療分野で用いられているこの技術は、心房細動や心室頻拍のような心臓のリズム障害の治療に有望である。PFAによる心臓アブレーションでは、制御された電気エネルギーが心臓組織に小さな傷を作り、不規則な電気信号を遮断することで規則正しい心拍を回復させる。

Framingham Heart Studyによると、心房細動の有病率は50年以上にわたって有意に増加している。疾病負担の増大と、心臓アブレーション以外のPFAの用途拡大を目指す進行中の研究が、予測期間中の大幅な市場成長の原動力になると予想される。

レポート範囲
 本レポートでは、治療領域、製品コンポーネント、応用領域、アブレーションの発生源、主要地域内のパルスフィールドアブレーションについて調査している。
 推進要因、阻害要因、機会、課題などの市場成長要因を分析しています。
 市場の潜在的な優位性と障害を評価し、主要市場プレイヤーの競争環境に関する洞察を提供します。
 主要3地域にわたる市場セグメントの収益に関する予測を行っています。
 詳細な概要では、正確性と信頼性を確保するための方法論、仮定、品質管理対策など、採用した厳密な調査方法について詳述している。
 パルス磁場アブレーション市場に影響を与える経済的影響について、過去の傾向、為替変動、外国為替の影響、景気後退の影響、インフレ測定などを含めてまとめています。
 調査中に得られた重要な洞察を簡潔にまとめ、パルスドフィールドアブレーション市場の現状と今後の展開に関するハイレベルな視点を提供しています。
 パルスフィールドアブレーションの包括的な紹介では、様々なアブレーション技術、システムコンポーネント、歴史的変遷、作用機序、治療用途、利点などを取り上げている。
 パルスフィールドアブレーション装置の現在の市場シナリオの分析には、製品コンポーネント、カテーテルの仕様、開発状況、応用分野、対象治療領域などが含まれる。さらに、特定の基準に基づき、機器開発に携わる企業の概要を提供しています。
 競争環境の評価では、企業の強さ、様々な基準に基づく製品競争力、パルス磁場アブレーション装置の開発状況を考慮している。
 主要パルス磁場アブレーション企業の詳細なプロフィールは、設立、従業員数、本社、財務実績（入手可能な場合）、製品範囲、最近の進歩、将来の展望を網羅している。
 パルスフィールドアブレーション装置開発に携わる主要企業の簡潔な表形式のプロフィールは、企業概要と製品ポートフォリオを強調している。
 パルス磁場アブレーション市場における最近の取り組みを詳細に精査し、提携分析、資金調達と投資動向、特許分析、業界関係者による世界的なイベントへの出席などを掲載しています。
 心臓マッピング・ナビゲーション装置分野の開発企業を詳細に調査し、設立年、企業規模、パルス磁場アブレーション装置開発企業との提携の可能性に焦点を当てる。
 徹底的な分析により、パルスフィールドアブレーション市場の成長に影響を与える要因を特定・解剖し、促進要因、阻害要因、新たな機会、既存の課題を網羅しています。

主要市場企業
 アキュパルス・メディカル
 アキュタス・メディカル
 アダージョメディカル
 アンジオダイナミクス
 アルガ・メドテック
 AtriAN Medical
 バイオセンス・ウェブスター
 ボストン・サイエンティフィック
 カーディオフォーカス
 CathRx
 CRC EP
 ガルバナイズ・セラピューティクス
 Gradient Medical
 Hangzhou Dinova EP Technology
 カルディウム
 メドトロニック
 みらいメディカル
 パルスバイオサイエンス
 天津インテリジェントヘルスメディカ

ページTOPに戻る


目次

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1 Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact / Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1 Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Future Estimates
3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry
3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution
4. EXECUTIVE SUMMARY
5. INTRODUCTION
5.1. Chapter Overview
5.2. Types of Ablation Techniques
5.3. Types of Catheter Ablation Techniques
5.3.1. Thermal Ablation Techniques
5.3.1.1. Radiofrequency Ablation
5.3.1.2. Laser Ablation
5.3.1.3. Microwave Ablation
5.3.1.4. Hydrothermal Ablation
5.3.1.5. High-Intensity Focused Ultrasound Ablation
5.3.2. Non-Thermal Ablation Techniques
5.3.2.1. Cryoablation
5.3.2.2. Mechanico-Chemical Ablation
5.3.2.3. Pulsed Field Ablation
5.4. Overview of Pulsed Field Ablation Therapy
5.4.1. Historical Evolution
5.4.2. Mechanism of Action
5.4.3. Therapeutic Applications
5.4.4. Advantages of Pulsed Field Ablation
5.5. Concluding Remarks
6. PULSED FIELD ABLATION DEVICES: MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Pulsed Field Ablation Devices: Overall Market Landscape
6.2.1. Analysis by Product Components
6.2.2. Analysis by Shape of Catheter
6.2.3. Analysis by Configuration of Catheter
6.2.4. Analysis by Type of Catheter (by Irrigation)
6.2.5. Analysis by Catheter Shaft Diameter
6.2.6. Analysis by Number of Electrodes
6.2.7. Analysis by Electrical Polarity
6.2.8. Analysis by Source of Ablation
6.2.9. Analysis by Status of Development
6.2.10. Analysis by Application Area
6.2.11. Analysis by Status of Development and Location of Clinical Trial
6.2.12. Analysis by Target Therapeutic Area and Target Indication
6.2.13. Analysis by Status of Development and Target Therapeutic Area
6.2.14. Analysis by Location of Clinical Trial and Target Therapeutic Area
6.2.15 Analysis by Source of Ablation, Application Area, and Target Therapeutic Area
6.3. Pulsed Field Ablation Device Developers: Overall Market Landscape
6.3.1. Analysis by Year of Establishment
6.3.2. Analysis by Company Size
6.3.3. Analysis by Location of Headquarters
6.3.4. Analysis by Company Size and Location of Headquarters (Region)
6.3.5. Analysis by Type of Developer
6.3.6. Analysis by Company Ownership
6.3.7. Analysis by Company Ownership and Location of Headquarters (Region)
6.3.8. Most Active Players: Analysis by Number of Products
7. PRODUCT COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Product Competitiveness Analysis: Pulsed Field Ablation Devices
7.4.1. Pulsed Field Ablation Devices Offered by Players based in North America
7.4.2. Pulsed Field Ablation Devices Offered by Players based in Europe
7.4.3. Pulsed Field Ablation Devices Offered by Players based in Asia-Pacific
7.5. Concluding Remarks
8. PULSED FIELD ABLATION DEVICE DEVELOPERS: DETAILED COMPANY PROFILES
8.1. Chapter Overview
8.2. Boston Scientific
8.2.1. Company Overview
8.2.2. Financial Information
8.2.3. Pulsed Field Ablation Portfolio
8.2.4. Recent Developments and Future Outlook
8.3. Medtronic
8.3.1. Company Overview
8.3.2. Financial Information
8.3.3. Pulsed Field Ablation Portfolio
8.3.4. Recent Developments and Future Outlook
8.4. Galvanize Therapeutics
8.4.1. Company Overview
8.4.2. Pulsed Field Ablation Portfolio
8.4.3. Recent Developments and Future Outlook
8.5. Pulse Biosciences
8.5.1. Company Overview
8.5.2. Pulsed Field Ablation Portfolio
8.5.3. Recent Developments and Future Outlook
8.6. AngioDynamics
8.6.1. Company Overview
8.6.2. Financial Information
8.6.3. Pulsed Field Ablation Portfolio
8.6.4. Recent Developments and Future Outlook
8.7. Biosense Webster
8.7.1. Company Overview
8.7.2. Pulsed Field Ablation Portfolio
8.7.3. Recent Developments and Future Outlook
8.8. Acutus Medical
8.8.1. Company Overview
8.8.2. Financial Information
8.8.3. Pulsed Field Ablation Portfolio
8.8.4. Recent Developments and Future Outlook
8.9. Kardium
8.9.1. Company Overview
8.9.2. Pulsed Field Ablation Portfolio
8.9.3. Recent Developments and Future Outlook
9. PULSED FIELD ABLATION DEVICE DEVELOPERS: TABULATED COMPANY PROFILES
9.1. Chapter Overview
9.2. Abbott
9.3. AccuPulse Medical
9.4. Argá Medtech
9.5. AtriAN Medical
9.6. AuriGen Medical
9.7. CathRx
9.8. ElectroPhysiology Frontiers
9.9. EnChannel Medical
9.10. Hangzhou Dinova EP Technology
9.11. Mirai Medical
9.12. Tianjin Intelligent Health Medical
10. RECENT DEVELOPMENTS AND INITIATIVES
10.1 Chapter Overview
10.2 Partnerships and Collaborations
10.2.1. Partnership Models
10.2.2. Pulsed Field Ablation: Partnerships and Collaborations
10.2.3. Analysis by Year of Partnership
10.2.4. Analysis by Type of Partnership
10.2.5. Analysis by Year and Type of Partnership
10.2.6. Analysis by Type of Product
10.2.7. Analysis by Type of Partnership and Type of Solution
10.2.8. Analysis by Therapeutic Area
10.2.9. Analysis by Type of Partnership and Therapeutic Area
10.2.10. Most Active Players: Analysis by Number of Partnerships
10.2.11. Analysis by Geography
10.2.11.1. Intercontinental and Intracontinental Agreements
10.2.11.2. Local and International Agreements
10.3. Funding and Investments
10.3.1. Funding Models
10.3.2. Pulsed Field Ablation: Funding and Investments
10.3.3. Analysis by Year of Investment
10.3.3.1. Cumulative Year-wise Trend of Funding Instances
10.3.3.2. Cumulative Year-wise Trend of Amount Invested
10.3.4. Analysis by Type of Funding
10.3.4.1. Analysis of Funding Instances
10.3.4.2. Analysis of Amount Invested
10.3.5. Analysis by Year and Type of Funding
10.3.5.1. Analysis of Funding Instances
10.3.5.2. Analysis of Amount Invested
10.3.6. Analysis of Funding Instances and Amount Invested by Therapeutic Area
10.3.7. Most Active Players: Analysis by Funding Instances
10.3.8. Most Active Players: Analysis by Amount Raised
10.3.9. Leading Investors: Analysis by Funding Instances
10.3.10. Analysis of Funding Instances and Amount Invested by Geography
11. PATENT ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Pulsed Field Ablation: Patent Analysis
11.3.1. Analysis by Patent Application Year
11.3.2. Analysis by Patent Publication Year
11.3.3. Analysis by Type of Patent and Patent Publication Year
11.3.4. Analysis by Publication Time
11.3.5. Analysis by Patent Jurisdiction
11.3.6. Analysis by CPC Symbols
11.3.7. Analysis by Type of Applicant
11.3.8. Analysis by Patent Age
11.3.9. Leading Players: Analysis by Number of Patents
11.3.10. Leading Patent Assignees: Analysis by Number of Patents
11.4. Pulsed Field Ablation: Patent Benchmarking Analysis
11.4.1. Analysis of Top CPC Codes by Leading Industry Players
11.4.2. Analysis of Top CPC Codes by Publication Time
11.5. Pulsed Field Ablation: Patent Valuation
12. GLOBAL EVENTS ANALYSIS
12.1. Chapter Overview
12.2. Scope and Methodology
12.3. Pulsed Field Ablation: Global Events
12.3.1. Analysis by Year of Event
12.3.2. Analysis by Type of Event
12.3.3. Analysis by Year and Type of Event
12.3.4. Analysis by Event Platform
12.3.5. Analysis by Location of Event
12.3.6. Word Cloud Analysis: Evolutionary Trends in Event Agenda / Key Focus Areas
12.3.7. Most Active Event Organizers: Analysis by Number of Events
12.3.8. Most Active Players: Analysis by Number of Events
12.4. Global Events: Speaker Analysis
12.4.1. Most Active Speakers: Analysis by Number of Events
12.4.2. Analysis by Designation of Speakers
12.5. Concluding Remarks
13. CASE STUDY: POTENTIAL PARTNERS OF PULSED FIELD ABLATION DEVICE DEVELOPERS
13.1. Chapter Overview
13.2. Cardiac Mapping and Navigation Device Developers
13.2.1 Analysis by Year of Establishment
13.2.2 Analysis by Company Size
13.2.3 Analysis by Location of Headquarters
13.3. Likely Partner Analysis
13.3.1. Assumptions and Key Parameters
13.3.2. Methodology
13.4. Potential Strategic Partners for Cardiac Pulsed Field Ablation Device Developers
13.4.1. Cardiac Mapping and Navigation Device Developers: Most Likely Partners
13.4.2. Cardiac Mapping and Navigation Device Developers: Likely Partners
13.4.3. Cardiac Mapping and Navigation Device Developers: Less Likely Partners
14. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
14.1. Chapter Overview
14.2. Market Drivers
14.3. Market Restraints
14.4. Market Opportunities
14.5. Market Challenges
14.6. Conclusion
15. GLOBAL PULSED FIELD ABLATION MARKET
15.1. Chapter Overview
15.2. Forecast Methodology and Key Assumptions
15.3. Global Pulsed Field Ablation Market, Historical Trends (2018-2022) and Future Estimates (2023-2035)
15.3.1. Scenario Analysis
15.4. Key Market Segmentations
15.5. Dynamic Dashboard
16. PULSED FIELD ABLATION MARKET, BY GEOGRAPHY
16.1. Chapter Overview
16.2. Forecast Methodology and Key Assumptions
16.3. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.4. Europe: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
16.5. Asia-Pacific: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
16.6. Data Triangulation
16.6.1. Insights from Secondary Research
16.6.2. Insights from In-house Repository
16.6.3. Dynamic Dashboard
17. PULSED FIELD ABLATION MARKET, BY THERAPEUTIC AREA
17.1. Chapter Overview
17.2. Forecast Methodology and Key Assumptions
17.3. Cardiovascular Disorders: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
17.4. Oncological Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.5. Respiratory Disorders: Historical Trends (2020-2022) and Forecasted Estimates (2023-2035)
17.6. Dermatological Disorders: Historical Trends (2022) and Forecasted Estimates (2023-2035)
17.7. Data Triangulation
17.7.1. Insights from Secondary Research
17.7.2. Insights from In-house Repository
17.7.3. Dynamic Dashboard
18. PULSED FIELD ABLATION MARKET, BY PRODUCT COMPONENTS
18.1. Chapter Overview
18.2. Forecast Methodology and Key Assumptions
18.3. Catheters: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
18.4. Generators: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.5. Data Triangulation
18.5.1. Insights from Secondary Research
18.5.2. Insights from In-house Repository
18.5.3. Dynamic Dashboard
19. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY PRODUCT COMPONENTS
19.1. Chapter Overview
19.2. Forecast Methodology and Key Assumptions
19.3. Catheters: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
19.4. Generators: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
19.5. Data Triangulation
19.5.1. Insights from Secondary Research
19.5.2. Insights from In-house Repository
19.5.3. Dynamic Dashboard
20. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY APPLICATION AREA
20.1. Chapter Overview
20.2. Forecast Methodology and Key Assumptions
20.3. Ablation: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
20.4. Ablation and Mapping: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
20.5. Data Triangulation
20.5.1. Insights from Secondary Research
20.5.2. Insights from In-house Repository
20.5.3. Dynamic Dashboard
21. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY SOURCE OF ABLATION
21.1. Chapter Overview
21.2. Forecast Methodology and Key Assumptions
21.3. Pulsed Field: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
21.4. Pulsed Field and Radiofrequency: Historical Trends (2021-2022) and Future Estimates (2023-2035)
21.5. Pulsed Field and Cryoablation: Historical Trends (2021-2022) and Future Estimates (2023-2035)
21.6. Data Triangulation
21.6.1. Insights from Secondary Research
21.6.2. Insights from In-house Repository
21.6.3. Dynamic Dashboard
22. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY GEOGRAPHY
22.1. Chapter Overview
22.2. Forecast Methodology and Key Assumptions
22.3. North America: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.3.1. US: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.3.2. Canada: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.4. Europe: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.5. Asia-Pacific: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.5.1. China: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.5.2. Japan: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.6. Data Triangulation
22.6.1. Insights from Secondary Research
22.6.2. Insights from In-house Repository
22.6.3. Dynamic Dashboard
23. PULSED FIELD ABLATION MARKET FOR ONCOLOGICAL DISORDERS, BY GEOGRAPHY
23.1. Chapter Overview
23.2. Forecast Methodology and Key Assumptions
23.3. North America: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
23.4. Europe: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
23.5. Asia-Pacific: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
23.6. Data Triangulation
23.6.1. Insights from Secondary Research
23.6.2. Insights from In-house Repository
23.6.3. Dynamic Dashboard
24. PULSED FIELD ABLATION MARKET FOR ONCOLOGICAL DISORDERS, BY PRODUCT COMPONENTS
24.1. Chapter Overview
24.2. Forecast Methodology and Key Assumptions
24.3. Catheters: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
24.4. Generators: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
24.5. Data Triangulation
24.5.1. Insights from Secondary Research
24.5.2. Insights from In-house Repository
24.5.3. Dynamic Dashboard
25. PULSED FIELD ABLATION MARKET FOR ONCOLOGICAL DISORDERS, BY TYPE OF CANCER
25.1. Chapter Overview
25.2. Forecast Methodology and Key Assumptions
25.3. Soft Tissue Ablative Cancers: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.4. Pancreatic Cancer: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.5. Prostate Cancer: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.6 Non-Small Cell Lung Cancer: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.7 Esophageal Cancer: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.8 Data Triangulation
25.8.1. Insights from Secondary Research
25.8.2 Insights from In-house Repository
25.8.3. Dynamic Dashboard
26. PULSED FIELD ABLATION MARKET FOR RESPIRATORY DISORDERS, BY GEOGRAPHY
26.1 Chapter Overview
26.2. Forecast Methodology and Key Assumptions
26.3. North America: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
26.4. Europe: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
26.5. Asia-Pacific: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
26.6. Data Triangulation
26.6.1. Insights from Secondary Research
26.6.2. Insights from In-house Repository
26.6.3. Dynamic Dashboard
27. PULSED FIELD ABLATION MARKET FOR RESPIRATORY DISORDERS, BY PRODUCT COMPONENTS
27.1 Chapter Overview
27.2. Forecast Methodology and Key Assumptions
27.3. Catheters : Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
27.4. Generators: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
27.5. Data Triangulation
27.5.1. Insights from Secondary Research
27.5.2. Insights from In-house Repository
27.5.3. Dynamic Dashboard
28. PULSED FIELD ABLATION: SALES FORECAST OF LEADING PLAYERS
28.1. Chapter Overview
28.2. Boston Scientific: Pulsed Field Ablation Sales Forecast (2023-2035)
28.3. Medtronic: Pulsed Field Ablation Sales Forecast (2023-2035)
28.4. Galvanize Therapeutics: Pulsed Field Ablation Sales Forecast (2023-2035)
28.5. AngioDynamics: Pulsed Field Ablation Sales Forecast (2023-2035)
29. CONCLUDING REMARKS
30. APPENDIX 1: TABULATED DATA
31. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

　

ページTOPに戻る


　

Summary

The pulsed field ablation market is expected to reach USD 5.5 billion by 2035 anticipated to grow at a CAGR of 40% during the forecast period 2023-2035.

In recent years, there's been a focused effort among medical practitioners to explore less invasive procedures for better patient outcomes, especially in conditions like atrial fibrillation. While traditional surgeries work, they bring issues like scarring, longer recovery, and higher risks. Ablation therapies, which use energy sources to eliminate abnormal tissues without surgery, have become popular. Yet, the usual methods using heat energy can harm healthy tissue and cause discomfort post-procedure. Pulsed field ablation (PFA) has emerged as a safer option. PFA uses high-voltage electrical pulses in short bursts to precisely target abnormal tissues without harming healthy cells. Unlike thermal ablation, PFA reduces risks and discomfort during recovery by avoiding tissue overheating. This technique, used in various medical areas, shows promise in treating cardiac rhythm disorders like atrial fibrillation and ventricular tachycardia. In cardiac ablation with PFA, controlled electrical energy creates small scars in cardiac tissue, restoring a regular heartbeat by blocking irregular electrical signals.

Atrial fibrillation's prevalence has significantly increased over 50 years, as per the Framingham Heart Study. The rising disease burden and ongoing research aiming to expand PFA's uses beyond cardiac ablation are expected to drive substantial market growth in the projected period.

Report Coverage
 The report investigates pulsed field ablation within therapeutic area, product components, application areas, source of ablation, and key geographical regions
 It analyzes market growth factors such as drivers, restraints, opportunities, and challenges.
 The report evaluates potential market advantages and obstacles, providing insights into the competitive landscape for leading market players.
 Forecasts are made regarding revenue in market segments across three major regions.
 An in-depth outline details the rigorous research methodology employed, including methodologies, assumptions, and quality control measures to ensure accuracy and reliability.
 Economic influences impacting the pulsed field ablation market, encompassing historical trends, currency fluctuations, foreign exchange impacts, recessionary effects, and inflation measurements, are summarized.
 A concise summary captures key insights obtained during research, offering a high-level perspective on the current state and future evolution of the pulsed field ablation market.
 A comprehensive introduction to pulsed field ablation covers various ablation techniques, system components, historical evolution, mechanism of action, therapeutic applications, and advantages.
 Analysis of the current market scenario for pulsed field ablation devices includes product components, catheter specifications, development status, application areas, and target therapeutic domains. Additionally, it provides an overview of companies involved in device development based on specific criteria.
 Assessment of the competitive landscape considers company strength, product competitiveness based on various criteria, and development status of pulsed field ablation devices.
 Detailed profiles of leading pulsed field ablation companies encompass their establishment, workforce, headquarters, financial performance (if available), product range, recent advancements, and future prospects.
 Concise tabulated profiles of significant companies involved in pulsed field ablation device development emphasize company overview and product portfolio.
 Detailed scrutiny of recent initiatives within the pulsed field ablation market includes partnership analyses, funding and investment trends, patent analyses, and global event attendance by industry players.
 A detailed examination of developers in the cardiac mapping and navigation device sector focuses on establishment years, company sizes, and potential partnerships with pulsed field ablation device developers.
 An exhaustive analysis identifies and dissects factors influencing the growth of the pulsed field ablation market, encompassing drivers, restraints, emerging opportunities, and existing challenges.

Key Market Companies
 AccuPulse Medical
 Acutus Medical
 Adagio Medical
 AngioDynamics
 Arga Medtech
 AtriAN Medical
 Biosense Webster
 Boston Scientific
 CardioFocus
 CathRx
 CRC EP
 Galvanize Therapeutics
 Gradient Medical
 Hangzhou Dinova EP Technology
 Kardium
 Medtronic
 Mirai Medical
 Pulse Biosciences
 Tianjin Intelligent Health Medica



ページTOPに戻る


Table of Contents

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1 Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact / Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1 Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Future Estimates
3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry
3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution
4. EXECUTIVE SUMMARY
5. INTRODUCTION
5.1. Chapter Overview
5.2. Types of Ablation Techniques
5.3. Types of Catheter Ablation Techniques
5.3.1. Thermal Ablation Techniques
5.3.1.1. Radiofrequency Ablation
5.3.1.2. Laser Ablation
5.3.1.3. Microwave Ablation
5.3.1.4. Hydrothermal Ablation
5.3.1.5. High-Intensity Focused Ultrasound Ablation
5.3.2. Non-Thermal Ablation Techniques
5.3.2.1. Cryoablation
5.3.2.2. Mechanico-Chemical Ablation
5.3.2.3. Pulsed Field Ablation
5.4. Overview of Pulsed Field Ablation Therapy
5.4.1. Historical Evolution
5.4.2. Mechanism of Action
5.4.3. Therapeutic Applications
5.4.4. Advantages of Pulsed Field Ablation
5.5. Concluding Remarks
6. PULSED FIELD ABLATION DEVICES: MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Pulsed Field Ablation Devices: Overall Market Landscape
6.2.1. Analysis by Product Components
6.2.2. Analysis by Shape of Catheter
6.2.3. Analysis by Configuration of Catheter
6.2.4. Analysis by Type of Catheter (by Irrigation)
6.2.5. Analysis by Catheter Shaft Diameter
6.2.6. Analysis by Number of Electrodes
6.2.7. Analysis by Electrical Polarity
6.2.8. Analysis by Source of Ablation
6.2.9. Analysis by Status of Development
6.2.10. Analysis by Application Area
6.2.11. Analysis by Status of Development and Location of Clinical Trial
6.2.12. Analysis by Target Therapeutic Area and Target Indication
6.2.13. Analysis by Status of Development and Target Therapeutic Area
6.2.14. Analysis by Location of Clinical Trial and Target Therapeutic Area
6.2.15 Analysis by Source of Ablation, Application Area, and Target Therapeutic Area
6.3. Pulsed Field Ablation Device Developers: Overall Market Landscape
6.3.1. Analysis by Year of Establishment
6.3.2. Analysis by Company Size
6.3.3. Analysis by Location of Headquarters
6.3.4. Analysis by Company Size and Location of Headquarters (Region)
6.3.5. Analysis by Type of Developer
6.3.6. Analysis by Company Ownership
6.3.7. Analysis by Company Ownership and Location of Headquarters (Region)
6.3.8. Most Active Players: Analysis by Number of Products
7. PRODUCT COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Product Competitiveness Analysis: Pulsed Field Ablation Devices
7.4.1. Pulsed Field Ablation Devices Offered by Players based in North America
7.4.2. Pulsed Field Ablation Devices Offered by Players based in Europe
7.4.3. Pulsed Field Ablation Devices Offered by Players based in Asia-Pacific
7.5. Concluding Remarks
8. PULSED FIELD ABLATION DEVICE DEVELOPERS: DETAILED COMPANY PROFILES
8.1. Chapter Overview
8.2. Boston Scientific
8.2.1. Company Overview
8.2.2. Financial Information
8.2.3. Pulsed Field Ablation Portfolio
8.2.4. Recent Developments and Future Outlook
8.3. Medtronic
8.3.1. Company Overview
8.3.2. Financial Information
8.3.3. Pulsed Field Ablation Portfolio
8.3.4. Recent Developments and Future Outlook
8.4. Galvanize Therapeutics
8.4.1. Company Overview
8.4.2. Pulsed Field Ablation Portfolio
8.4.3. Recent Developments and Future Outlook
8.5. Pulse Biosciences
8.5.1. Company Overview
8.5.2. Pulsed Field Ablation Portfolio
8.5.3. Recent Developments and Future Outlook
8.6. AngioDynamics
8.6.1. Company Overview
8.6.2. Financial Information
8.6.3. Pulsed Field Ablation Portfolio
8.6.4. Recent Developments and Future Outlook
8.7. Biosense Webster
8.7.1. Company Overview
8.7.2. Pulsed Field Ablation Portfolio
8.7.3. Recent Developments and Future Outlook
8.8. Acutus Medical
8.8.1. Company Overview
8.8.2. Financial Information
8.8.3. Pulsed Field Ablation Portfolio
8.8.4. Recent Developments and Future Outlook
8.9. Kardium
8.9.1. Company Overview
8.9.2. Pulsed Field Ablation Portfolio
8.9.3. Recent Developments and Future Outlook
9. PULSED FIELD ABLATION DEVICE DEVELOPERS: TABULATED COMPANY PROFILES
9.1. Chapter Overview
9.2. Abbott
9.3. AccuPulse Medical
9.4. Argá Medtech
9.5. AtriAN Medical
9.6. AuriGen Medical
9.7. CathRx
9.8. ElectroPhysiology Frontiers
9.9. EnChannel Medical
9.10. Hangzhou Dinova EP Technology
9.11. Mirai Medical
9.12. Tianjin Intelligent Health Medical
10. RECENT DEVELOPMENTS AND INITIATIVES
10.1 Chapter Overview
10.2 Partnerships and Collaborations
10.2.1. Partnership Models
10.2.2. Pulsed Field Ablation: Partnerships and Collaborations
10.2.3. Analysis by Year of Partnership
10.2.4. Analysis by Type of Partnership
10.2.5. Analysis by Year and Type of Partnership
10.2.6. Analysis by Type of Product
10.2.7. Analysis by Type of Partnership and Type of Solution
10.2.8. Analysis by Therapeutic Area
10.2.9. Analysis by Type of Partnership and Therapeutic Area
10.2.10. Most Active Players: Analysis by Number of Partnerships
10.2.11. Analysis by Geography
10.2.11.1. Intercontinental and Intracontinental Agreements
10.2.11.2. Local and International Agreements
10.3. Funding and Investments
10.3.1. Funding Models
10.3.2. Pulsed Field Ablation: Funding and Investments
10.3.3. Analysis by Year of Investment
10.3.3.1. Cumulative Year-wise Trend of Funding Instances
10.3.3.2. Cumulative Year-wise Trend of Amount Invested
10.3.4. Analysis by Type of Funding
10.3.4.1. Analysis of Funding Instances
10.3.4.2. Analysis of Amount Invested
10.3.5. Analysis by Year and Type of Funding
10.3.5.1. Analysis of Funding Instances
10.3.5.2. Analysis of Amount Invested
10.3.6. Analysis of Funding Instances and Amount Invested by Therapeutic Area
10.3.7. Most Active Players: Analysis by Funding Instances
10.3.8. Most Active Players: Analysis by Amount Raised
10.3.9. Leading Investors: Analysis by Funding Instances
10.3.10. Analysis of Funding Instances and Amount Invested by Geography
11. PATENT ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Pulsed Field Ablation: Patent Analysis
11.3.1. Analysis by Patent Application Year
11.3.2. Analysis by Patent Publication Year
11.3.3. Analysis by Type of Patent and Patent Publication Year
11.3.4. Analysis by Publication Time
11.3.5. Analysis by Patent Jurisdiction
11.3.6. Analysis by CPC Symbols
11.3.7. Analysis by Type of Applicant
11.3.8. Analysis by Patent Age
11.3.9. Leading Players: Analysis by Number of Patents
11.3.10. Leading Patent Assignees: Analysis by Number of Patents
11.4. Pulsed Field Ablation: Patent Benchmarking Analysis
11.4.1. Analysis of Top CPC Codes by Leading Industry Players
11.4.2. Analysis of Top CPC Codes by Publication Time
11.5. Pulsed Field Ablation: Patent Valuation
12. GLOBAL EVENTS ANALYSIS
12.1. Chapter Overview
12.2. Scope and Methodology
12.3. Pulsed Field Ablation: Global Events
12.3.1. Analysis by Year of Event
12.3.2. Analysis by Type of Event
12.3.3. Analysis by Year and Type of Event
12.3.4. Analysis by Event Platform
12.3.5. Analysis by Location of Event
12.3.6. Word Cloud Analysis: Evolutionary Trends in Event Agenda / Key Focus Areas
12.3.7. Most Active Event Organizers: Analysis by Number of Events
12.3.8. Most Active Players: Analysis by Number of Events
12.4. Global Events: Speaker Analysis
12.4.1. Most Active Speakers: Analysis by Number of Events
12.4.2. Analysis by Designation of Speakers
12.5. Concluding Remarks
13. CASE STUDY: POTENTIAL PARTNERS OF PULSED FIELD ABLATION DEVICE DEVELOPERS
13.1. Chapter Overview
13.2. Cardiac Mapping and Navigation Device Developers
13.2.1 Analysis by Year of Establishment
13.2.2 Analysis by Company Size
13.2.3 Analysis by Location of Headquarters
13.3. Likely Partner Analysis
13.3.1. Assumptions and Key Parameters
13.3.2. Methodology
13.4. Potential Strategic Partners for Cardiac Pulsed Field Ablation Device Developers
13.4.1. Cardiac Mapping and Navigation Device Developers: Most Likely Partners
13.4.2. Cardiac Mapping and Navigation Device Developers: Likely Partners
13.4.3. Cardiac Mapping and Navigation Device Developers: Less Likely Partners
14. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
14.1. Chapter Overview
14.2. Market Drivers
14.3. Market Restraints
14.4. Market Opportunities
14.5. Market Challenges
14.6. Conclusion
15. GLOBAL PULSED FIELD ABLATION MARKET
15.1. Chapter Overview
15.2. Forecast Methodology and Key Assumptions
15.3. Global Pulsed Field Ablation Market, Historical Trends (2018-2022) and Future Estimates (2023-2035)
15.3.1. Scenario Analysis
15.4. Key Market Segmentations
15.5. Dynamic Dashboard
16. PULSED FIELD ABLATION MARKET, BY GEOGRAPHY
16.1. Chapter Overview
16.2. Forecast Methodology and Key Assumptions
16.3. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.4. Europe: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
16.5. Asia-Pacific: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
16.6. Data Triangulation
16.6.1. Insights from Secondary Research
16.6.2. Insights from In-house Repository
16.6.3. Dynamic Dashboard
17. PULSED FIELD ABLATION MARKET, BY THERAPEUTIC AREA
17.1. Chapter Overview
17.2. Forecast Methodology and Key Assumptions
17.3. Cardiovascular Disorders: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
17.4. Oncological Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.5. Respiratory Disorders: Historical Trends (2020-2022) and Forecasted Estimates (2023-2035)
17.6. Dermatological Disorders: Historical Trends (2022) and Forecasted Estimates (2023-2035)
17.7. Data Triangulation
17.7.1. Insights from Secondary Research
17.7.2. Insights from In-house Repository
17.7.3. Dynamic Dashboard
18. PULSED FIELD ABLATION MARKET, BY PRODUCT COMPONENTS
18.1. Chapter Overview
18.2. Forecast Methodology and Key Assumptions
18.3. Catheters: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
18.4. Generators: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.5. Data Triangulation
18.5.1. Insights from Secondary Research
18.5.2. Insights from In-house Repository
18.5.3. Dynamic Dashboard
19. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY PRODUCT COMPONENTS
19.1. Chapter Overview
19.2. Forecast Methodology and Key Assumptions
19.3. Catheters: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
19.4. Generators: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
19.5. Data Triangulation
19.5.1. Insights from Secondary Research
19.5.2. Insights from In-house Repository
19.5.3. Dynamic Dashboard
20. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY APPLICATION AREA
20.1. Chapter Overview
20.2. Forecast Methodology and Key Assumptions
20.3. Ablation: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
20.4. Ablation and Mapping: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
20.5. Data Triangulation
20.5.1. Insights from Secondary Research
20.5.2. Insights from In-house Repository
20.5.3. Dynamic Dashboard
21. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY SOURCE OF ABLATION
21.1. Chapter Overview
21.2. Forecast Methodology and Key Assumptions
21.3. Pulsed Field: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
21.4. Pulsed Field and Radiofrequency: Historical Trends (2021-2022) and Future Estimates (2023-2035)
21.5. Pulsed Field and Cryoablation: Historical Trends (2021-2022) and Future Estimates (2023-2035)
21.6. Data Triangulation
21.6.1. Insights from Secondary Research
21.6.2. Insights from In-house Repository
21.6.3. Dynamic Dashboard
22. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY GEOGRAPHY
22.1. Chapter Overview
22.2. Forecast Methodology and Key Assumptions
22.3. North America: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.3.1. US: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.3.2. Canada: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.4. Europe: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.5. Asia-Pacific: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.5.1. China: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.5.2. Japan: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.6. Data Triangulation
22.6.1. Insights from Secondary Research
22.6.2. Insights from In-house Repository
22.6.3. Dynamic Dashboard
23. PULSED FIELD ABLATION MARKET FOR ONCOLOGICAL DISORDERS, BY GEOGRAPHY
23.1. Chapter Overview
23.2. Forecast Methodology and Key Assumptions
23.3. North America: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
23.4. Europe: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
23.5. Asia-Pacific: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
23.6. Data Triangulation
23.6.1. Insights from Secondary Research
23.6.2. Insights from In-house Repository
23.6.3. Dynamic Dashboard
24. PULSED FIELD ABLATION MARKET FOR ONCOLOGICAL DISORDERS, BY PRODUCT COMPONENTS
24.1. Chapter Overview
24.2. Forecast Methodology and Key Assumptions
24.3. Catheters: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
24.4. Generators: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
24.5. Data Triangulation
24.5.1. Insights from Secondary Research
24.5.2. Insights from In-house Repository
24.5.3. Dynamic Dashboard
25. PULSED FIELD ABLATION MARKET FOR ONCOLOGICAL DISORDERS, BY TYPE OF CANCER
25.1. Chapter Overview
25.2. Forecast Methodology and Key Assumptions
25.3. Soft Tissue Ablative Cancers: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.4. Pancreatic Cancer: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.5. Prostate Cancer: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.6 Non-Small Cell Lung Cancer: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.7 Esophageal Cancer: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.8 Data Triangulation
25.8.1. Insights from Secondary Research
25.8.2 Insights from In-house Repository
25.8.3. Dynamic Dashboard
26. PULSED FIELD ABLATION MARKET FOR RESPIRATORY DISORDERS, BY GEOGRAPHY
26.1 Chapter Overview
26.2. Forecast Methodology and Key Assumptions
26.3. North America: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
26.4. Europe: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
26.5. Asia-Pacific: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
26.6. Data Triangulation
26.6.1. Insights from Secondary Research
26.6.2. Insights from In-house Repository
26.6.3. Dynamic Dashboard
27. PULSED FIELD ABLATION MARKET FOR RESPIRATORY DISORDERS, BY PRODUCT COMPONENTS
27.1 Chapter Overview
27.2. Forecast Methodology and Key Assumptions
27.3. Catheters : Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
27.4. Generators: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
27.5. Data Triangulation
27.5.1. Insights from Secondary Research
27.5.2. Insights from In-house Repository
27.5.3. Dynamic Dashboard
28. PULSED FIELD ABLATION: SALES FORECAST OF LEADING PLAYERS
28.1. Chapter Overview
28.2. Boston Scientific: Pulsed Field Ablation Sales Forecast (2023-2035)
28.3. Medtronic: Pulsed Field Ablation Sales Forecast (2023-2035)
28.4. Galvanize Therapeutics: Pulsed Field Ablation Sales Forecast (2023-2035)
28.5. AngioDynamics: Pulsed Field Ablation Sales Forecast (2023-2035)
29. CONCLUDING REMARKS
30. APPENDIX 1: TABULATED DATA
31. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

Roots Analysis社の分野での最新刊レポート

  • 最新刊レポートはありません。

本レポートと同じKEY WORD（）の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Roots Analysis社はどのような調査会社ですか?


Roots Analysisは2013年設立の医薬品・医療機器が専門の調査会社です。 医薬品の製造委託や創薬のデジタル化など、最新の医薬業界の分析を行っています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22　10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.